NUVB
Nuvation Bio Inc
5.70$
+0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +0.0% | +443.6% | -49.3% | +685.6% | -46.0% | +56.7% | +171.5% | +219.1% | +98.8% | -61.9% | – | |
| – | +0.0% | +5.5% | +2,222.4% | +12.5% | +178.3% | -50.3% | +23.0% | +30.0% | -87.4% | +1,227.7% | -83.8% | – | |
| – | – | -127.8% | – | -995.5% | – | -33.8% | +128.0% | +332.9% | +324.1% | +87.3% | -60.3% | – | |
| – | -17.3% | -16.3% | +3,437.7% | -93.9% | +5.7% | -16.0% | +11.2% | +5.4% | +18.9% | +2.2% | -12.5% | – | |
| – | -29.5% | +34.3% | +112.8% | +20.6% | +34.7% | +39.1% | +6.2% | -1.9% | +9.4% | -5.0% | +11.2% | – | |
| – | -20.9% | -3.0% | +2,229.2% | -89.9% | +17.2% | +8.2% | +9.8% | +0.5% | +14.0% | -2.3% | +11.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -1,415.0% | – | |
| – | – | +0.0% | -97.2% | -9.1% | -25.8% | -39.3% | +679.6% | +1,452.0% | +2.1% | +0.5% | +0.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -1,264.4% | – | |
| – | – | -99.9% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -1,264.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -539.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.